News Room
Another take on TP-102 Phase I/IIa Clinical Trial by Jornal Expresso
During the development of TP-102 a lot of journals published pieces describing this great Technophage's milestone. This year, Jornal Expresso,...
Technophage granted with the ‘COTEC Innovative Status 2021’
Technophage is proud to announce that it has recently been granted with the 'COTEC Innovative Status 2021'. COTEC Portugal is the main Portuguese...
Technophage’s efforts to tackle COVID-19 in 2021
During this last year, Technophage has been dedicated to the development of a new biologic product for COVID-19. The company has been working...
Pipeline
Invest in our products
GMP manufacturing
Learn more about GMP manufacturing
Technophage
Who we are, What we do
Therapeutic
areas
TechnoPhage is committed to the development of biological and chemical products for infection, neurosciences and ophthalmology